A new dimeric isocoumarin, bireticulol, was isolated from the terrestrial Streptomyces sp. and characterized as a 5-5¢ dimer of reticulol. In addition, reticulol and 8-hydroxy-6,7-dimethoxy-3-methyl isocoumarin, together with other known polyketides piericidin A, 2¢-(2-hydroxyphenyl)-2,4¢-bibenzoxazole-4-carboxylic acid methyl ester (UK-1) and 3-benzyl-4-hydroxy-5-methyldihydrofuran-2-one were also obtained. Bireticulol exhibited cytotoxic effects against KB (human epidermoid carcinoma, ATCC CCL-17) and NCI-H187 (human small cell lung cancer, ATCC CRL-5804) cell lines with IC 50 values of 24.4 and 8.31 lg ml À1 , respectively.
INTRODUCTION
Isocoumarins belong to an important class of secondary metabolites that display a diverse biological activities 1 such as antifungal, 2 antimicrobial, 3 antitumor, 4 anti-inflammatory, 5 antiallergic, 6 antimalarial 7 and antioxidant 8 effects. A wide range of isocoumarins have been obtained from various natural sources because of their remarkable bioactivities continue to attract and stimulate interest in many research areas. Although a significant number of isocoumarins have been isolated, there seemed to be not many reports regarding the dimeric form of naturally occurring isocoumarins. Few of those included the biisocoumarin, castanaguyone 9 and the antifungal metabolite tithoniamarin. 10 As part of the program to explore actinomycetes from Thailand that exhibit distinct biological activities, Streptomyces sp. BCC24731 was selected for further investigation. The initial screening indicated that BCC24731 was effective in malarial inhibition assay against Plasmodium falciparum K1 strain with moderate cytotoxicity against MCF7. Using bioassay guided-fractionation, a new dimeric isocoumarin, bireticulol (1) , has been isolated in addition to its monomer counterpart, reticulol (2) (see ref. 11) , and the closely related derivative, 8-hydroxy-6,7-dimethoxy-3-methyl isocoumarin (3) (see refs 12,13) . Other several known polyketides were also derived from this strain including piericidin A (4) (see refs 14,15) , UK-1 (5) (see refs 16,17 ) and 3-benzyl-4-hydroxy-5-methyldihydrofuran-2-one (6) (see refs 18,19) . This paper describes the fermentation, isolation, structural elucidation and semi-synthesis of 1 together with the biological activities of these compounds (Figure 1 ).
RESULTS AND DISCUSSION
Structure elucidation of 1, isolated as a yellow amorphous powder, was based on ESI-TOF HRMS and NMR data ( 13 C NMR spectra, which were only half of that expected from the molecular formula, it could be deduced that this compound possesses a symmetrical dimer skeleton.
Positions of substituted functional groups in 1 were assigned by analysis of COSY and HMBC NMR spectral data ( Figure 2) . The methyl protons H-9/H-9¢ showed HMBC correlations to C-3/C-3¢ and C-4/C-4¢, as well as illustrated COSY long-range correlation coupling to olefinic methine proton at H-4/H-4¢, which confirmed the methyl substitution at C-3/C-3¢. The position of the hydroxy groups at C-8/C-8¢ was assigned by HMBC correlations from the proton signal at d 11.56 to the aromatic carbons at C-7/C-7¢, C-8/C-8¢ and C-8a/C-8a¢. HMBC correlation from the methoxy proton signal at H-10/H-10¢ to the aromatic carbon at d 133.6 defined the substitution of methoxy groups at C-7/C-7¢.
The framework of isocoumarin ring system and its connection to the other moiety were determined by HMBC NMR spectral data and the comparison of 13 C NMR data with its monomer counterpart, reticulol (2). 13 C NMR spectroscopic data of 1 was discovered to be very similar to the corresponding data of 2. The only difference was that each proton signal at H-5/H-5¢ had disappeared and was, instead, replaced with the aromatic quaternary carbon signals at d 107.3 (C-5/ C-5¢). HMBC correlations from the aromatic methine proton signals H-4/H-4¢ to the carbons C-5/C-5¢ defined the substitution pattern of the carbon-carbon linkage at the position C-5/C-5¢. Thus, the structure of 1 can be established as 6,6¢,8,8¢-tetrahydroxy-7, 7¢-dimethoxy-3,3¢-dimethyl-5,5¢-biisocoumarin.
For the confirmation of the structure, the semi-synthetic reaction has been used to construct 1 via an intermolecular oxidative coupling reaction. Treatment of 2 with Iron (III) chloride (FeCl 3 ) was carried out under the condition that utilized meta-chloroperbenzoic acid (m-CPBA) as the oxidant and dry CH 2 Cl 2 as its solvent system 20 ( Figure 3 ). The product of 1 was obtained in 14% yield. The spectroscopic data of semi-synthetic 1 were identical in all respect to the naturally occurring compound.
As 1 is a symmetrical dimer of 2 with carbon-carbon bond that was characterized as a 5-5¢ dimer, given that a large amount of 2 have also been obtained from the same Streptomyces, there was a possibility that 1 might be formed as artifact during the isolation process. Rapid extraction method of crude actinomycete followed by the analysis using HPLC was carried out. The result illustrated the presence of 1 in the crude extract, suggesting that 1 was produced by the microorganism and not an artifact.
Bireticulol (1) and compounds 2-6 were evaluated for cytotoxicity against MCF-7 (human breast cancer), KB (human epidermoid carcinoma), NCI-H187 (human small cell lung cancer), Vero cell lines and antimalarial activity against Plasmodium falciparum K1 strain (multi-drug resistant strain). These compounds were also tested for antibacterial activities against S. aureus, B. cereus and E. coli. In addition, they were further investigated for anti-TB, antifungal activities against C. albicans and plant pathogen M. grisea. Results showed that none of the obtained metabolites were active in the anti-TB, anti-M. grisea or the antibacterial assays. As for antimalarial and antifungal activities, only piericidin A (4) exhibited inhibition against Plasmodium falciparum K1 at IC 50 of 3.45 mg ml À1 and inhibited C. albicans with MIC value of 5.33 mg ml À1 . All of the tested compounds were also reported to be non-cytotoxic against Vero cells. Biological activities against different cancer cell lines including MCF-7, KB and NCI-H187 were determined and results are illustrated in Table 2 .
The newly derived 1 along with other known isocoumarins and polyketides are reported in this study to express moderate to weak cytotoxic activities against MCF-7, KB and NCI-H187 cell lines. Bireticulol exhibited cytotoxicity against KB cell lines with IC 50 values of 24.4 mg ml À1 , while expressed inhibition against NCI-H187 cell lines at IC 50 of 8.31 mg ml À1 . Interestingly, 2 showed no inhibition against all three cancer cell lines. The presence of dimeric skeleton apparently increased inhibitory activities of 1 in these anti-cancer assays. In addition, comparison of cytotoxic activities between 2 and its closely related derivative 3 also illustrated a similar trend. The presence of a methoxy group instead of a hydroxyl at position C-6 in 3 seemed to have effect on its biological activities, as 3 also exhibited inhibition against all the three cancer cell lines, whereas 2 expressed none. For other known isolated metabolites, which are not isocoumarin related, 4 and 5 showed moderate to weak bioactivities against all the three cancer cell lines, whereas 6 was inactive against all of them.
EXPERIMENTAL PROCEDURE General
UV spectrum was obtained using a GBC Cintra 404 UV-visible spectrophotometer (GBC Scientific Equipment, Victoria, Australia). FT-IR spectrum was recorded on a Bruker VECTOR 22 spectrometer (Bruker Optik GmbH, Ettlingen, Germany). 1 H, 13 Bireticulol, a bioactive isocoumarin dimer C Boonlarppradab et al
Bruker micrOTOF mass spectrometer (Bruker Daltonik GmbH, Bremen, Germany) in positive mode.
Biological material
Streptomyces sp. (BCC 24731/A-T 0762) was isolated from the soil under bamboo trees collected at evergreen forest, Khuean Srinagarindra National Park, Kanchanaburi, Thailand. The collection and taxonomic identification were performed by Chanwit Suriyachadkun (BIOTEC). This actinomycete strain was previously identified as Streptoverticillium sp. A specimen has been deposited at BIOTEC Culture Collection (BCC) and registered as BCC 24731.
Culture condition
Streptomyces BCC 24731 was maintained on ISP2 (International Streptomyces Project 2) medium at 28 1C for 21 days. The agar plate culture was chopped into pieces (1Â1 cm 2 ) and transferred to 250 ml Erlenmeyer flasks, containing 25 ml of Bio 19 liquid medium at pH 7. The Bio 19 medium consisted of (w/v): glucose, 2%; peptone, 0.5%; yeast extract, 0.3%; meat extract, 0.5%; NaCl, 0.05%; CaCO 3 , 0.3%. The seed culture was incubated at 28 o C on a rotary shaker (250 r.p.m.) for 7 days. Later, the seed culture was inoculated into 1000 ml Erlenmeyer flasks containing 250 ml of Bio 19 liquid medium, and incubated at 28 o C on a rotary shaker (250 r.p.m.) for 7 days.
Large-scale fermentation
Approximately 600 ml of seed culture was inoculated into 10 l fermentor vessel (BMT, B.E. Marubishi, Thailand) containing 6 l of production medium LS2 (pH 6. 
Extraction and isolation
After 7 days, the organic constituents from a 6 l culture of Streptomyces sp. strain BCC24731 were extracted by a solid-phase extraction method using Amberlite XAD-7 resin (Supelco, Bellefonte, PA, USA). Amberlite XAD-7 resin (20 g l À1 ) was added to 6 l of culture to adsorb the organic substances. The culture and resin were shaken at 200 r.p.m. overnight and subsequently filtered through cheesecloth and washed with deionized water. The resin and the cheesecloth were submerged in acetone and shaken at 200 r.p.m. for 3 h to elute out all substances. The crude acetone extract was dried in vacuo to yield a dark brown substance (10.9 g), which was partitioned by Diaion HP20SS (Supelco, Bellefonte, PA, USA) column chromatography (3.5Â25 cm, acetone:water) to yield nine fractions (20, 30, 40 , 50, 60, 70, 80, 90 and 100% acetone mixtures).
Crystals were found to establish in 60 and 70% fractions, and could be later identified as 2 (362.8 mg). The fraction eluted with 100% acetone was found to contain white precipitated solid, which after crystalization from chloroform/ methanol mixtures (80/20), gave the pure compound 5 (33 mg).
After the removal of crystals, all other fractions were concentrated to dryness and evaluated using NMR profiles. The fraction which eluted with 60% acetonewater (280 mg) was subjected to further purification by gradient preparative HPLC using a reversed-phase column (Phenomenex Luna 10 m C18 (2) 100A, 21.2Â250 mm, 10 mm (Phenomenex LUNA, Torrance, CA, USA); 10 ml min À1 , 30% MeCN/H 2 O over 10 min, 30-35% MeCN/H 2 O over 5 min, 35-40% MeCN/H 2 O over 25 min) to give 6 (13.9 mg). The 70% acetone-water fraction (383 mg) was also subjected to the purification by gradient HPLC (Phenomenex Luna C 18 preparative, 10 ml min À1 , 20-100% MeCN/H 2 O over 60min) to afford 1 (7.4 mg), 2 (239.9 mg) and 3 (12.7 mg). The 80% (418 mg) and 90% (510 mg) acetone-water fractions were further purified by gradient HPLC (Phenomenex Luna C 18 preparative, 10 ml min À1 , 20-100% MeCN/H 2 O over 40 min) to yield 1 (9.3 mg), 2 (17 mg), and 4 (199 mg).
Bireticulol (1)
Yellow amorphous powder; UV (MeOH) l max (log e) 243 nm (3.74 
Preparation of bireticulol by oxidative coupling reaction
Anhydrous FeCl 3 (0.4 mg, 0.003 mmol) and m-CPBA (4.3 mg, 0.025 mmol) were added to a solution of 2 (2, 5.1 mg, 0.023 mmol) in dry CH 2 Cl 2 (5 ml). The reaction solution was stirred at room temperature overnight then quenched with H 2 O (5 ml). The aqueous phase was extracted with CH 2 Cl 2 and the combined organic phase was evaporated in vacuo to yield the lightyellow substance. The crude material from the reaction was further purified by gradient HPLC (Phenomenex Luna C 18 preparative, 10 ml min À1 , 20-100% MeCN/H 2 O over 60 min) to afford bireticulol (1, 0.7 mg).
Biological assays
Cytotoxicity against Vero cell (African green monkey kidney fibroblasts, ATCC CCL-81) was determined using the green fluorescent protein (GFP)-based assay, 21 whereas cytotoxic tests against cancer cell lines, including KB (human epidermoid carcinoma, ATCC CCL-17), MCF-7 (human breast cancer, ATCC HTB-22), and NCI-H187 (human small cell lung cancer, ATCC CRL-5804) were performed using the resazurin microplate assay (REMA). 22 Antimalarial activity against Plasmodium falciparum K1 was tested by the microculture radio isotope technique. 23 Antimicrobial assays were also carried out using the resazurin microplate technique. 24 Anti-mycobacterium tuberculosis (H 37 Ra strain) assay was performed using GFP microplate assay (GFPMA). 25 Anti-rice blast disease pathogen (Magnaporthe grisea) assay was carried out by using the method of 5,(6)-carboxy fluorescene diacetate (CFDA) fluorometric detection. 26 
